Rossi, R.E.; Lavezzi, E.; Jaafar, S.; Cristofolini, G.; Laffi, A.; Nappo, G.; Carrara, S.; Bertuzzi, A.F.; Uccella, S.; Repici, A.;
et al. Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art. Cancers 2023, 15, 4065.
https://doi.org/10.3390/cancers15164065
AMA Style
Rossi RE, Lavezzi E, Jaafar S, Cristofolini G, Laffi A, Nappo G, Carrara S, Bertuzzi AF, Uccella S, Repici A,
et al. Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art. Cancers. 2023; 15(16):4065.
https://doi.org/10.3390/cancers15164065
Chicago/Turabian Style
Rossi, Roberta Elisa, Elisabetta Lavezzi, Simona Jaafar, Giacomo Cristofolini, Alice Laffi, Gennaro Nappo, Silvia Carrara, Alexia Francesca Bertuzzi, Silvia Uccella, Alessandro Repici,
and et al. 2023. "Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art" Cancers 15, no. 16: 4065.
https://doi.org/10.3390/cancers15164065
APA Style
Rossi, R. E., Lavezzi, E., Jaafar, S., Cristofolini, G., Laffi, A., Nappo, G., Carrara, S., Bertuzzi, A. F., Uccella, S., Repici, A., Zerbi, A., & Lania, A. G. A.
(2023). Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art. Cancers, 15(16), 4065.
https://doi.org/10.3390/cancers15164065
